KBL Merger Corp. IV SPAC Signs Definitive Business Combination Agreement to Acquire CannBioRx Life Sciences Corp. Jul 26, 2019 9:00am EDT
KBL Merger Corp. IV SPAC Announces Non-Binding Term Sheet to Acquire CannBioRx Life Sciences Corp. and its Three Interactive Programs May 14, 2019 8:00am EDT
KBL Merger Corp. IV Announces Closing of Underwriters' Over-Allotment Option in Full in Connection with its Initial Public Offering and Separate Trading of its Common Stock, Rights and Warrants, Commencing June 27, 2017 Jun 23, 2017 4:32pm EDT
KBL Merger Corp. IV Announces Pricing of $100 Million Initial Public Offering Jun 01, 2017 8:21pm EDT
